Mr. Tony O'Brien:

Let me express a corporate view based on what we now know, particularly what we now know from the exercise in which the SIMT has engaged to establish how many patients actually were told. Clearly, it was a flawed process. Clearly, too much time was spent in trying to resolve disagreements. Had the matter been escalated, as it ought to have been much sooner, at a corporate level we would clearly have intervened to make sure the objective which was communication to patients would have happened. A key lesson is that there was probably too much time spent in trying to come up with a "perfect methodology". As time passed, that pursuit should have ended and the process of communication should have started.